Deleting MyD88 or TLR2/4 from bone marrow-derived immune cells significantly reduces diabetes-induced pathological changes in the retina such as leucostasis, vascular permeability, superoxide generation and intercellular adhesion molecule 1 (ICAM-1) (76). Here, ICAM1 is linked to diabetes mellitus.